Trulieve Cannabis (TRLV) Equity Average (2020 - 2026)

Trulieve Cannabis (TRLV) has reported Equity Average for 7 consecutive years, with $1.1 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Equity Average fell 7.11% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (down 7.11% YoY), while the FY2025 annual figure was $1.2 billion, down 9.99% from the prior year.
• Equity Average came in at $1.1 billion for Q1 2026 at Trulieve Cannabis, down from $1.2 billion in the prior quarter.
• The five-year high for Equity Average was $2.1 billion in Q1 2022, with the low at $1.1 billion in Q1 2026.
• Average Equity Average over 5 years is $1.5 billion, with a median of $1.4 billion recorded in 2024.
• Across the five-year window, Equity Average soared 357.06% in 2022 and slipped 29.73% in 2023, its largest moves.
• Year by year, Equity Average stood at $2.0 billion in 2022, then dropped by 27.66% to $1.4 billion in 2023, then decreased by 10.52% to $1.3 billion in 2024, then declined by 8.64% to $1.2 billion in 2025, then fell by 1.59% to $1.1 billion in 2026.
• According to Business Quant data, Equity Average over the past three periods registered $1.1 billion, $1.2 billion, and $1.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.